Attention: Vivalto Partners is the target of a phishing campaign impersonating its president, Daniel Caille. Do not click on links in emails from a fake Daniel Caille.
Vivalto Partners announces the 100% acquisition of Linnea -a leading international pharmaceutical manufacturer of botanical ingredients-, formerly a joint-venture between Ipsen and Schwabe, through a primary buyout supported by management.